Royalty Report: Food, Nutrition, Beverages – Collection: 280979

$150.00

Curated Royalty Rate Report
Category: Technology Licenses, Created On: 2022-04-28, Record Count: 10

Description

This collection of transactions and supporting information was developed using our AI algorithm to curate similar royalty reports into a cohesive collection to support your licensing, transfer pricing or other transaction scenarios where documented royalty rates and/or deal terms are important.
Category: Technology Licenses
Created On: 2022-04-28
Record Count: 10

Primary Industries

  • Food
  • Nutrition
  • Beverages
  • Healthcare
  • Drugs
  • Nutraceutical
  • Supplements
  • Technical Know How

IPSCIO Report Record List

Below you will find the records curated into this collection.  This summary includes the complete licensed property description so that you can review and determine if this collection covers the topics, technology or transaction type that is relevant for your needs.  The full report will include all relevant deal data such as the royalty base, agreement date, term description, royalty rates and other deal terms.  For reference, here is a sample of a full IPSCIO curated royalty rate report: Sample Report

IPSCIO Record ID: 280979

License Grant
Licensor grants, under the Licensed Patents, the Technology, and Licensors other proprietary rights, for the term of this Agreement and subject to the conditions of this Agreement, a nonexclusive right and license, in the Territory, to use, make or have made triglycerides containing Omega-3 and/ 01· Omega-G long-chain polyunsaturated fatty acids for the production of the Licensee Product, to use the Licensor Products for purposes of producing the Licensee Product; and (iii) the right to use, market, import, export, distribute, offer for sale and sell the Licensee Product.

Licensor grants to Licensee, under the Licensed Patents, the Technology, and Licensors other proprietary rights, for the term of this Agreement and subject to the conditions of this Agreement, a nonexclusive right in the Territory, to grant non-exclusive, non-transferable sublicenses to Third Party sublicensees to sell triglycerides containing Omega-3 and/ or Omega.6 longchain polyunsaturated fatty acids by microbial fermentation according to the Technology, and,  to make and sell triglycerides containing Omega-3 and/ Ol Omega-G long-chain polyunsaturated fatty acids and/ or Licensee Product exclusively for Licensee.

Licensor grants to Licensee the non-exclusive, right and license to use the Trademarks solely on and in connection with the sale of any Licensee Product that contains a Licensor Product, with the further agreement that Licensee may elect to so use the Trademarks at Licensees sole discretion.

License Property
Licensor has developed certain technology relating to the use of Omega-3 and Omega-6 long-chain polyunsaturated fatty acid-containing triglycerides for incorporation into infant formula.

Infant Formula Product shall mean a breast milk substitute formulated industrially in accordance with applicable Codex Alimentarius and United States Food and Drug Administration standards to satisfy the total normal nutritional requirements of infants from birth up to between four and six months of age and adapted to their physiological characteristics or fed in addition to other foods to infants up to approximately one year of age and older or to satisfy the normal nutritional requirements of infants born prematurely.

The patents are for Arachidonoc acid and methods for the production and use thereof,  Docosahexaenoic Acid, Methods for its Production and Compounds Containing the Same,  and, Microbial Oil Mixtures and Uses Thereof.  

The marks include Neuromins, Arasco, Dhasco, and Formulaid.

Field of Use
Licensee and its affiliates are in the business of developing, manufacturing and marketing infant nutritional products.

IPSCIO Record ID: 372590

License Grant
Licensor grants to Licensee of Switzerland, under the Licensed Patents, the Technology, and Licensor’s other proprietary rights, a non-exclusive right and license, in the Territory, directly or through sublicense to an Affiliate, to incorporate, or permit a Designee to incorporate, the Licensor Products provided hereunder into or with one or more Infant Formula Products to produce the Licensee Product and to use, market, import, export, distribute, offer for sale and sell the Licensee Product.

Licensor grants the non-exclusive, right and license to use the Trademarks solely on and in connection with the sale of any Licensee Product that contains a Licensor Product, with the further agreement that Licensee may elect to so use the Trademarks at Licensee’s sole discretion.

License Property
Licensor has developed certain technology relating to the use of Omega-3 and Omega-6 long-chain polyunsaturated fatty acid-containing triglycerides for incorporation into infant formula.

Infant Formula Product shall mean a breast milk substitute formulated industrially in accordance with applicable Codex Alimentarius and/or United States Food and Drug Administration standards to satisfy the total normal nutritional requirements of infants from birth up to between four and six  months of age and adapted to their physiological characteristics or fed in addition to other foods to infants up to approximately one year of age and older or to satisfy the normal nutritional requirements of infants born prematurely, as well as nutritional requirements of infants with special dietary needs.

Licensee Product shall mean any product which is an Infant Formula Product, which is developed and/or manufactured by or for Licensee or its Affiliates, which bears Licensee’s brand or the brand of an Affiliate and which if sold in any country where any Licensed Patent has issued, would infringe any such Licensed Patent.

Licensor Products shall mean triglycerides containing Omega-3 and/or Omega-6 long-chain polyunsaturated fatty acids produced by or for Licensor, by microbial fermentation according to Licensor’s technology and the Licensed Patents.

Trademarks shall mean the Licensor trademarks FORMULAID, NEUROMINS, DHASCO and ARASCO.

Field of Use
Licensee and its affiliates are in the business of developing, manufacturing and marketing infant nutritional products.

IPSCIO Record ID: 238981

License Grant
Licensor grants to Licensee of the Netherlands a non-exclusive, non-transferable right and license, directly or through an Affiliate, to use the Technology for the production of the Nutricia Formulaid Product within the Territory,  to use and make within the Territory the Licensor Product for purposes of producing the Nutricia Formulaid Product within the Territory, and, to use, market and distribute by sale within the Territory the Nutricia Formulaid Product.

In addition to the license granted hereunder relating to the Martek Product and the Technology, Licensor hereby grants to Licensee the non-exclusive, non-transferable right and license to use the Trademark solely on, and in connection with the manufacture and sale of, the Nutricia Formulaid Product.

License Property
Licensor has developed certain technology relating to the production by microbial fermentation of Omega-3 and Omega-6 long-chain polyunsaturated fatty acid-containing triglycerides for possible incorporation into infant formula.

Infant Formula Product shall mean a breast milk substitute formulated industrially in accordance with applicable Codex Alimentarius standards to satisfy the total normal nutritional requirements of infants up to between four and six months of age and adapted to their physiological characteristics and fed in addition to other foods to infants up to approximately one year of age.

Licensor Product, shall mean triglycerides containing Omega-3 and/or Omega-6 long-chain polyunsaturated fatty acids produced by microbial fermentation using the Technology.

“Trademark” shall mean the trademark “Formulaid”.

Field of Use
Licensee is in the business of developing, manufacturing and marketing infant nutritional products.

IPSCIO Record ID: 237241

License Grant
Licensor grants a non-exclusive, non-transferable right and license, in the Territory, directly or through sublicense to an Affiliate, to use the Technology for the production of the Licensee Formulaid Product, to use and make the Licensor Product for purposes of producing the Licensee Formulaid Product and to use, market and distribute by sale the Licensee Formulaid Product itself or through its Affiliates.

Licensor shall be entitled to grant any license to any Third Party relating to the Technology, the Licensor Product or the Licensed Patents.

In addition to the license granted hereunder relating to the Licensor Product and the Technology, Licensor grants to Licensee the non-exclusive, non-transferable right and license to use the Trademark solely on, and in connection with the manufacture and sale of, the licensee Formulaid Product.

License Property
Licensor has developed certain technology relating to the production by microbial fermentation of Omega-3 and Omega-6 long-chain polyunsaturated fatty acid-containing triglycerides for possible incorporation into infant formula.

“AHPC Formulaid Product” shall mean a product (I) which is an Infant Formula Product..

Infant Formula Product” shall mean a breast milk substitute formulated.

Trademark shall mean the trademark FORMULAID.

Field of Use
Licensee and its affiliates are in the business of developing, manufacturing and marketing infant nutritional products.

IPSCIO Record ID: 237240

License Grant
Licensor grants a non-exclusive, non-transferable right and license throughout the Territory, directly or through an Affiliate, under Licensed Patents and the Technology,  to produce the Licensee Product, to use and make the Licensor Product for purposes of making and having made the Licensee Product and to use, market and distribute directly or indirectly the Licensee Product.

Licensor further grants to Licensee the option to add the territory of Europe to the license granted so that the Territory as defined herein will include all countries throughout the world, such option to be exercisable at any time during the term of this Agreement upon payment of an additional fee.

In addition to the license granted relating to the Licensor Product and the Technology, Licensor grants to Licensee the non-exclusive, non-transferable right and license to use throughout the Territory the Trademark solely on, and in connection with the manufacture and sale of, the Licensee Product.

License Property
Licensor has certain technology relating to the production by microbial fermentation of Omega-3 and Omega-6 long-chain polyunsaturated fatty acid-containing triglycerides for possible incorporation into infant formula

Technology shall mean the organisms, microorganisms, specifications, biological materials, designs, formulae, processes, standards, data, trade secrets, knowhow, copyrights and technology relating to the development and production of the Licensor Product and proprietary to Licensor and any modifications, improvements and enhancements to any of the foregoing made by Licensor, which, in Licensor’s opinion, is or are necessary in the production and development of the Licensor Product.

ARASCO shall mean a Licensor Product containing no less than 15% arachidonic acid by weight of fatty acids.

DHASCO shall mean a Licensor Product containing no less than 30% docosahexaenoic acid by weight of fatty acids.

The trademark shall mean FORMULAID.

Field of Use
Licensee is in the business of developing, manufacturing and marketing infant nutritional products.

IPSCIO Record ID: 6636

License Grant
Licensor hereby grants to Licensee, under the Licensed Patents, the Technology, and Licensor's other proprietary rights, for the term of this Agreement and subject to the conditions of this Agreement, a non-exclusive right and license, in the Territory, directly or through sublicense to an Affiliate, (i) to incorporate, or permit a Designee to incorporate, the Martek Products provided hereunder into or with one or more Infant Formula Products to produce the Licensee Product and (ii) to use, market, import, export, distribute, offer for sale and sell the Licensee Product.
License Property
Trademark(s) shall mean the Licensor trademarks Formulaid, Neuromins, Dhasco and Arasco.

Licensed Patents
5,374,657; 5,550,156; 5,658,767; 5,397,591; 5,407,957; 5,492,938; 5,711,983

Field of Use
The rights granted in this non-exclusive license for the certain technology relating to the use of Omega-3 and Omega-6 long-chain polyunsaturated fatty acid-containing triglycerides for incorporation into infant formula.

IPSCIO Record ID: 211865

License Grant
For the Intellectual Property License of Licensors Proprietary Technology, Licensor grants to the Licensee of the Netherlands,  a perpetual, exclusive, including as to Licensor, worldwide, non-assignable, sublicensable license under the Licensors Proprietary Technology, the Licensors R&D Patents, the Excluded Subject Matter and any amendments and updates thereof to make, use, have made, import, sell and offer for sale arachidonic acid or ARA Products and ARA Products combined with other products in the Licensee ARA Fields of Use and to make ARA Products for delivery to Licensor and to perform Extraction and RBD processing.  RBD means the combined processes of refining, bleaching and deodorizing Crude Oil.

The parties have developed certain complementary (and, in some cases, blocking) technology for the production, refining, and blending of arachidonic acid for use in infant formula to meet the nutritional needs of infants and as a potential nutritional supplement and/or food ingredient for young children, pregnant and lactating women, and adults generally. Licensor owns technology related to the manufacture and use of arachidonic acid and has certain issued patents and patents pending throughout the world, claiming certain processes for the manufacture of arachidonic acid, certain compounds and certain uses; and Licensee owns technology related to the manufacture of arachidonic acid and has certain issued patents and pending patent applications throughout the world, claiming certain processes for the manufacture of arachidonic acid, certain formulations for that product, certain compounds and certain applications. Licensor has also obtained certain governmental regulatory approvals for the use of arachidonic acid in infant formula.

Licensee shall use Licensors brand names and the Licensor trade name, solely on Licensors behalf and for Licensors benefit, on all shipments of ARA Products by Licensee to Licensor or any Licensor customer, pursuant to delivery or order instructions by Licensor to Licensee, and Licensee shall not attach any additional brand names, trademarks, trade names, logos or designations to any such shipment.

License Property
Licensors Proprietary Technology shall mean, collectively, all Licensor Patents and all Know-how necessary for or useful to the manufacture, processing or use of ARA Products that are, owned by Licensor or any Licensor Affiliate, and disclosed or required to be disclosed hereunder to Licensee including without limitation technology for the Extraction and RBD processing steps.

Arachidonic acid (ARA) is a polyunsaturated omega-6 fatty acid 204. It is structurally related to the saturated arachidic acid found in Cupuaçu butter.

Nutritional oils are comprised of fatty acid components, primarily arachidonic acid, commonly known as ARA.

Nutritional oils is used as ingredients in infant formula and foods, and as ingredients in, and encapsulated for use as, dietary supplements.

Many researchers believe that these fatty acids may enhance mental and visual development in infants and play a pivotal role in brain function throughout life.

Field of Use
Licensees ARA Fields of Use shall mean any Feed Products and other uses of ARA that are not for human oral consumption or for the purpose of providing ARA as a nutrient for humans.

Licensors ARA Fields of Use shall mean all ARA fields of use other than the Licensee ARA Fields of Use.

IPSCIO Record ID: 2911

License Grant
The Licensee entered into a License Agreement with the Licensor for certain patented technology expected to be used in the production of the Licensee's life’sDHA™. Under the Agreement, the Licensee was granted a perpetual and generally exclusive License to the technology.
License Property
Life’sDHA™ is a vegetarian source of the omega-3 fatty acid DHA (docosahexaenoic acid), for use in infant formula, pregnancy and nursing products, foods and beverages, dietary supplements and animal feed.
Field of Use
The rights granted apply to baby food.

IPSCIO Record ID: 211840

License Grant
Licensor grants an exclusive license, exclusive even as to Licensor in the Territory under Licensor Technology to use, sell, have sold, offer for sale, import and export Products in the Field.
License Property
Proprietary Technology relates to development and commercialization of a bioactive milk-based carbohydrate for use in infant and pediatric nutritional formulas.

The Covered Compound shall mean pure 3-sialyllactose or 6-sialyllactose or a mixture of both or lactose enriched with Sialyllactose in accordance with the Specifications.

The Product(s) shall mean any Pediatric Nutritional Composition(s) containing Covered Compound.

Field of Use
The Field shall mean the use of the Covered Compound in Pediatric Nutritional Compositions, in both powder and liquid form.

IPSCIO Record ID: 211822

License Grant
The University grants a worldwide, sole and exclusive right and license to make, have made, use, lease and sell the Licensed Products, with rights to sublicense.
License Property
Licensed products means any natural vegetable oil, genetically selected or engineered vegetable oil, blend of such oils, or any oil-based food without limitation, for any and all food uses, sold in any and all marketplaces, and providing a balance of saturated and polyunsaturated fatty acids to increase HDL and the HDL/LDL cholesterol ratio in human serum, for the specific purpose of claims of HDL/LDL balance which is covered by any patent rights or uses the technology.

Technology relating to the use of a balanced proportion of saturated and polyunsaturated fatty acids from one or more vegetable oil sources for incorporation into any and all food products to increase HDL and the HDL/LDL cholesterol ratio, and accompanying know-how.

Field of Use
This agreement is for the commercial field meaning any food service use, such as frying shortening for restaurants, or any industrial manufacturing use, such as shortening for commercial bakers.
Disclaimer: The information gathered from RoyaltySource® database was sourced from the U.S. Securities and Exchange Commission EDGAR Filings and other public records. While we believe the sources to be reliable, this does not guarantee the accuracy or completeness of the information provided. Further, the information is supplied as general guidance and is not intended to represent or be a substitute for a detailed analysis or professional judgment. This information is for private use only and may not be resold or reproduced without permission.